Nanobiotix is trading 11% up at $40.16, after rising from the August 10 closing price of $36.18; no confirmed company-specific catalyst was identified for August 11, 2026.
- Its investor-relations page lists the latest release on July 30.
- The S&P 500 and Nasdaq are slightly lower, while the Dow is higher.
- The advance may reflect trading activity or a delayed reaction to earlier clinical developments; causation remains unconfirmed.